Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.71689 | 73 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.88923 | 74 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.58437 | 72 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.58752 | 71 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.45732 | 71 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.3447 | 79 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.55229 | 72 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.57831 | 72 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.50927 | 71 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.39039 | 70 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.35585 | 70 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.86918 | 74 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.7199 | 73 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.37992 | 70 |